Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPartners Grp E Regulatory News (PEY)

Share Price Information for Partners Grp E (PEY)

Share Price is delayed by 15 minutes
Get Live Data
8.32    0.00 (0.00%)
Bid:
0.00
Ask:
9.10
Spread: 0.82 (9.903%)
Market Cap: €562.50m
PEY Live PriceLast checked at - London Stock Exchange

Intraday Partners Grp E Share Chart

Stable performance in July

25 Aug 2016 07:00

RNS Number : 0734I
Princess Private Equity Holding Ltd
25 August 2016
 

News Release

Guernsey, 25 August 2016

 

Stable performance in July

 

· Princess Private Equity Holding Limited's ("Princess") net asset value ("NAV") stands at EUR 9.78 per share

· Overall portfolio developments (+0.3%) were positive while currency movements (-0.1%) were slightly negative

· Princess received distributions of EUR 5.0 million from exited investments and invested EUR 13.2 million

 

Distributions during the month came predominantly from Princess' legacy third party fund portfolio (EUR 2.5 million). Princess also received proceeds of EUR 1.3 million following the realization of US-based semiconductor manufacturer Freescale Semiconductor. Partners Group first invested in Freescale as part of a consortium in 2006, but the company experienced a significant decline in orders during the financial crisis which required it to reduce its cost base. Freescale subsequently held its IPO in 2011, raising the necessary capital to restructure its debt and held a secondary offering in 2014. The company was acquired by Dutch competitor NXP Semiconductors in a cash-and-stock transaction in December 2015, which valued the combined enterprise at over USD 40 billion. Princess received the cash proceeds from the transaction in April this year and subsequently sold the stock component in July.

 

Princess invested a total of EUR 13.2 million during the month, of which EUR 11.6 million was allocated to PCI Pharma Services (PCI). Partners Group acquired the global pharmaceutical services provider from selling private equity firm Frazier Healthcare Partners. Headquartered in Philadelphia, USA, PCI offers outsourced services across the entire pharmaceutical supply chain, including drug development and manufacturing, clinical trials and packaging services. The company has a diverse customer base of more than 350 companies, including the world's leading pharmaceutical manufacturers. PCI employs more than 2'800 people across the US and Europe, and generated sales of over USD 475 million in 2015. Following the acquisition, Partners Group plans to work closely with PCI's management team to add more specialized offerings to the product range and expand the company, both organically and through complementary add-on acquisitions.

 

On 18 August Princess held a conference call to update investors on the company's performance and the development of its portfolio during the second quarter of 2016. The presentation and replay facility are now available on the company's website:

 

http://princess-privateequity.net/en/investor_relations/web_cast_live-events.php.

 

 

Further information is available in the monthly report which can be accessed via:

http://www.princess-privateequity.net/financialreports.

 

Ends.

 

About Princess

Princess is an investment holding company founded in 1999 and domiciled in Guernsey. It invests, inter alia, in private equity and private debt investments. Princess is advised in its investment activities by Partners Group, a global private markets investment management firm with over EUR 49 billion in investment programs under management in private equity, private debt, private real estate and private infrastructure. Princess aims to provide shareholders with long-term capital growth and an attractive dividend yield. Princess is traded on the London Stock Exchange (ticker symbol: PEY). Further information: www.princess-privateequity.net.

 

Contacts

Princess Private Equity Holding Limited:

princess@princess-privateequity.net

www.princess-privateequity.net

 

Registered Number: 35241

 

Investor relations contact

George Crowe

Phone: +44 (0)20 7575 2771

Email: george.crowe@partnersgroup.com

 

Media relations contact

Partners Group

Jenny Blinch

Phone: +41 41 784 65 26

Email: jenny.blinch@partnersgroup.com

www.partnersgroup.com

 

This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Princess. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about, and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein are not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan.

 

This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document. Neither the contents of Princess' website nor the contents of any website accessible from hyperlinks on Princess' website (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRBLGDIBXDBGLS
Date   Source Headline
4th Nov 20257:00 amRNSNAV increased by 2.1% in September
4th Nov 20257:00 amRNSSave the date for Q3 2025 results announcement
3rd Nov 20257:00 amRNSSale of Clario
30th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:02 amRNSSale of Apex Logistics
8th Oct 20257:00 amRNSFree Cash Flow and commencement of share buy backs
3rd Oct 20257:53 amRNSPartial sale of International Schools Partnership
3rd Oct 20257:05 amRNSPartial sale of International Schools Partnership
3rd Oct 20257:00 amRNSPGPE Ltd publishes August NAV
8th Sep 20257:00 amRNSNAV increased by 0.8% in July
4th Sep 20257:00 amRNSInclusion in FTSE 250 Index
28th Aug 20257:00 amRNSPGPE Ltd publishes Half-Year Report 2025
20th Aug 20257:00 amRNSSave the date for H1 2025 results announcement
12th Aug 20257:00 amRNSPGPE Ltd publishes June NAV
15th Jul 20257:11 amRNSSale of PCI Pharma Services
14th Jul 20259:05 amRNSUpdate regarding Techem
7th Jul 20257:00 amRNSPGPE Ltd publishes May NAV
23rd Jun 20253:52 pmRNSDirector/PDMR Shareholding
19th Jun 20254:00 pmRNSResults of Annual General Meeting
19th Jun 20257:05 amRNSDirector Declaration
19th Jun 20257:00 amRNSBlock sale of shares of Vishal Mega Mart
6th Jun 20257:00 amRNSPGPE Ltd publishes April NAV
28th May 20257:00 amRNSResults presentation webcast details
16th May 20257:00 amRNSSave the date for Q1 2025 results announcement
8th May 20257:00 amRNSPGPE Ltd publishes March NAV
30th Apr 20257:00 amRNSDividend Declaration
23rd Apr 20257:00 amRNSNotice of Annual General Meeting
4th Apr 20257:00 amRNSPGPE Ltd publishes February NAV
2nd Apr 20257:00 amRNSChanges to Board composition
31st Mar 20257:00 amRNSDirector/PDMR Shareholding
21st Mar 20257:00 amRNSAnnual results and webcast details
7th Mar 20257:00 amRNSSave the date for 2024 annual results announcement
7th Mar 20257:00 amRNSNAV increased by 0.5% in January
19th Feb 20257:00 amRNSAmendment to Investment Management Agreement
7th Feb 20257:00 amRNSNAV increases by 4.4% in December
8th Jan 20257:00 amRNSNAV increases by 1.2% in November
20th Dec 20247:15 amRNSVishal Mega Mart lists on Stock Exchanges in India
12th Dec 20246:09 pmRNSHolding(s) in Company
12th Dec 20246:01 pmRNSHolding(s) in Company
4th Dec 20247:00 amRNSNAV increases by 2.4% in October
21st Nov 20247:22 amRNSResults presentation webcast details
5th Nov 20247:00 amRNSSave the date for Q3 2024 results announcement
4th Nov 20247:00 amRNSNAV increases by 0.5% in September
28th Oct 20247:00 amRNSDirector/PDMR Shareholding
23rd Oct 202410:00 amRNSDividend Declaration
10th Oct 20247:15 amRNSPortfolio company prices IPO and lists on NYSE
4th Oct 20247:00 amRNSPGPE Ltd publishes August NAV
1st Oct 20247:15 amRNSSale of Techem
4th Sep 20247:00 amRNSPGPE Ltd publishes July NAV

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.